CD276 and glioblastoma: Notably, the expression of CD276 in GBM was positively correlated with neutrophil-mediated immunity, whereas it was negatively associated with regulation of neurotransmitter levels, neurotransmitter transport and neuropeptide signaling pathways (Fig. 14F-I).